セルベースアッセイ市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

セルベースアッセイの世界市場は、2024年に172億8,000万米ドルと評価され、2030年には278億8,000万米ドルに達し、CAGR 8.30％で拡大すると予測されています。

慢性疾患や希少疾患を対象とした革新的な治療薬に対する需要の高まりにより、同市場は力強い成長を遂げています。アウトブレイク時の治療薬採用の増加と研究開発活動の活発化が市場拡大を加速しています。世界のヘルスケア支出の増加と、医薬品開発における毒性スクリーニングのニーズの高まりが、細胞ベースのアッセイに対する需要の高まりにさらに寄与しています。これらのアッセイは、治療効率を改善し、創薬に関連するコストと時間を削減することで、従来の検査に代わる信頼性の高い選択肢を提供します。さらに、Menarini Silicon Biosystems社による多発性骨髄腫の血液ベースの分析用CELLSEARCHの発売など、先進治療の利点に対する意識の高まりや、研究を支援する政府の取り組みが、2030年までの市場の見通しを高めています。

市場促進要因

創薬・開発重視の高まり

市場の課題

先端アッセイ技術の高コスト

主要市場動向

人工知能とハイコンテントスクリーニングの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 臨床試験分析

第6章 世界のセルベースアッセイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品・サービス別（試薬、アッセイキット、マイクロプレート、プローブ・ラベル、細胞株、その他）
  • 用途別（臨床調査、医薬品の発見と開発、その他）
  • エンドユーザー別（バイオテクノロジー・製薬企業、学術・調査機関、契約調査機関）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 製品とサービス別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 北米のセルベースアッセイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第8章 欧州のセルベースアッセイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第9章 アジア太平洋地域のセルベースアッセイ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第10章 南米のセルベースアッセイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第11章 中東・アフリカのセルベースアッセイ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第12章 市場力学

• 促進要因
• 課題

第13章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第14章 世界のセルベースアッセイ市場：SWOT分析

第15章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第16章 競合情勢

• Corning, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

The Global Cell Based Assays Market was valued at USD 17.28 billion in 2024 and is anticipated to reach USD 27.88 billion by 2030, expanding at a CAGR of 8.30%. This market is witnessing robust growth due to the rising demand for innovative therapeutics targeting chronic and rare diseases. Increased adoption of therapeutic drugs during outbreaks, coupled with intensified research and development activities, is accelerating market expansion. The rising healthcare expenditure globally, coupled with a growing need for toxicity screening in drug development, further contributes to the rising demand for cell-based assays. These assays offer a reliable alternative to traditional testing by improving treatment efficiency and reducing the cost and time associated with drug discovery. Furthermore, growing awareness of the benefits of advanced therapies and government initiatives to support research-such as the launch of CELLSEARCH by Menarini Silicon Biosystems for blood-based analysis of multiple myeloma-are enhancing the market's outlook through 2030.

Key Market Drivers

Growing Emphasis on Drug Discovery and Development

The expanding landscape of drug discovery is a key factor fueling the growth of the cell-based assays market. These assays play a pivotal role in evaluating drug efficacy and toxicity by mimicking cellular environments to yield physiologically relevant data. With pharmaceutical companies screening extensive compound libraries, the adoption of cell-based assays has become integral to preclinical studies. The FDA's approval of over 50 new drugs in 2023 highlights the active pace of drug development, where cell-based models accelerate lead identification while reducing dependency on animal testing. The ability of these assays to support precision medicine through patient-specific data makes them invaluable. Significant government funding, such as the NIH's $45 billion allocation in 2023, reinforces research in advanced screening technologies, driving the global uptake of cell-based assays as an accurate, ethical, and cost-effective solution in drug development pipelines.

Key Market Challenges

High Cost of Advanced Assay Technologies

A major obstacle in the cell-based assays market is the high cost associated with deploying advanced technologies. The acquisition and maintenance of sophisticated equipment like automated imaging systems, robotic handlers, and microplate readers demand large capital investments. Reagents, software, and consumables further add to operational costs. These financial demands can hinder adoption, especially among small research institutions, academic labs, and organizations in lower-income regions. Budget constraints in public institutions and uneven distribution of funding-largely concentrated in North America and Europe-amplify the challenge. Additionally, a shortage of trained personnel to operate complex systems and interpret intricate data creates further barriers. Without targeted support through technology-sharing initiatives, subsidized programs, or collaborative partnerships, the global adoption of these platforms may remain limited to wealthier regions.

Key Market Trends

Integration of Artificial Intelligence and High-Content Screening

A transformative trend in the market is the fusion of artificial intelligence (AI) with high-content screening (HCS) technologies. HCS platforms generate vast cellular datasets using automated imaging, which are now being analyzed using AI-driven tools that enhance accuracy and reduce human error. These algorithms facilitate faster, real-time interpretation of complex biological activities such as cell morphology and apoptosis, making drug screening more scalable and reliable. Government-backed research programs like the U.S. NAIRR initiative promote the use of AI in biomedical applications, including cell-based research. As labs seek efficiency, reproducibility, and scalability, the integration of AI with cell-based assay platforms is rapidly becoming a central element in modern drug screening and development strategies.

Key Market Players

• Corning, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• F. Hoffmann-La Roche AG
• Merck KGaA
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.

Report Scope:

In this report, the Global Cell Based Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Based Assays Market, By Product & Services:

• Reagents
• Assay Kits
• Microplates
• Probes & Labels
• Cell Lines
• Others

Cell Based Assays Market, By Application:

• Clinical Research
• Drug Discovery & Development
• Others

Cell Based Assays Market, By End User:

• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutions
• Contract Research Organizations

Cell Based Assays Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Based Assays Market.

Available Customizations:

Global Cell Based Assays Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

• 5.1. Ongoing Clinical Trials
• 5.2. Completed Clinical Trials
• 5.3. Terminated Clinical Trials
• 5.4. Breakdown of Pipeline, By Development Phase
• 5.5. Breakdown of Pipeline, By Status
• 5.6. Breakdown of Pipeline, By Study Type
• 5.7. Breakdown of Pipeline, By Region
• 5.8. Clinical Trials Heat Map

6. Global Cell Based Assays Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others)
  • 6.2.2. By Application (Clinical Research, Drug Discovery & Development, Others)
  • 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations)
  • 6.2.4. By Region
  • 6.2.5. By Company (2024)
• 6.3. Market Map
  • 6.3.1. By Products & Services
  • 6.3.2. By Application
  • 6.3.3. By End User
  • 6.3.4. By Region

7. North America Cell Based Assays Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products & Services
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Cell Based Assays Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Canada Cell Based Assays Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Mexico Cell Based Assays Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User

8. Europe Cell Based Assays Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products & Services
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Cell Based Assays Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Germany Cell Based Assays Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. United Kingdom Cell Based Assays Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Italy Cell Based Assays Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Spain Cell Based Assays Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Asia-Pacific Cell Based Assays Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products & Services
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Cell Based Assays Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. India Cell Based Assays Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Japan Cell Based Assays Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User
  • 9.3.4. South Korea Cell Based Assays Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Products & Services
      • 9.3.4.2.2. By Application
      • 9.3.4.2.3. By End User
  • 9.3.5. Australia Cell Based Assays Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Products & Services
      • 9.3.5.2.2. By Application
      • 9.3.5.2.3. By End User

10. South America Cell Based Assays Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products & Services
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell Based Assays Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Argentina Cell Based Assays Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Colombia Cell Based Assays Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Middle East and Africa Cell Based Assays Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Products & Services
  • 11.2.2. By Application
  • 11.2.3. By End User
  • 11.2.4. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Cell Based Assays Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Products & Services
      • 11.3.1.2.2. By Application
      • 11.3.1.2.3. By End User
  • 11.3.2. Saudi Arabia Cell Based Assays Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Products & Services
      • 11.3.2.2.2. By Application
      • 11.3.2.2.3. By End User
  • 11.3.3. UAE Cell Based Assays Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Products & Services
      • 11.3.3.2.2. By Application
      • 11.3.3.2.3. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Mergers & Acquisitions
• 13.3. Product Launches

14. Global Cell Based Assays Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products/Services

16. Competitive Landscape

• 16.1. Corning, Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Bio-Rad Laboratories, Inc.
• 16.3. Thermo Fisher Scientific Inc.
• 16.4. Danaher Corporation
• 16.5. Lonza Group AG
• 16.6. Promega Corporation
• 16.7. F. Hoffmann-La Roche AG
• 16.8. Merck KGaA
• 16.9. Charles River Laboratories International, Inc.
• 16.10. Menarini Silicon Biosystems, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer